Informazioni
Non ci sono recensioni
Osteoporosis: Pathophysiology and Epidemiology
Pages 1-16
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
The Duration and Safety of Osteoporosis Treatment
Anabolic and Antiresorptive Therapy
Silverman, Abrahamsen
Editore
Springer
Anno
2016
Pagine
338
ISBN
9783319236384
120,00 €
- Focuses on the duration and safety of anabolic and antiresorptive drug therapies for osteoporosis
- Examines common and serious side effects of extended drug treatment, especially bisphosphonates
- Discusses diagnosis and management of osteonecrosis of the jaw and atypical femur fractures
Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and future pharmaceuticals. Leading practitioners in the field examine all current literature and data regarding the duration and safety of these therapies, with recommendations for clinicians on decision-making and best practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture risk assessment and an examination of treatment failures. Next, a number of chapters are dedicated to the diagnosis, presentation and management of atypical femur fractures and osteonecrosis of the jaw (ONJ), each of which are significant patient concerns when using these osteoporosis treatments. The introduction and utilization of drug holidays is also discussed, as well as the long-term outlook for management of osteoporotic patients. Written and edited by experts in the field, The Duration and Safety of Osteoporosis Treatment is a balanced resource for researchers, practitioners and policy-makers alike for clinical decision-making and patient care.
Table of contents (23 chapters)
